- Home
- ROC vs INMB Comparison
ROC vs INMB Comparison
Compare ROC & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROC | INMB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 64.7M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ROC | INMB |
|---|---|---|
| Price | $3.66 | $1.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $7.75 | $7.00 |
| AVG Volume (30 Days) | 25.4K | ★ 264.5K |
| Earning Date | 08-13-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,979,679.00 | $50,000.00 |
| Revenue This Year | $21.30 | N/A |
| Revenue Next Year | $72.97 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 23.90 | ★ 257.14 |
| 52 Week Low | $3.35 | $1.09 |
| 52 Week High | $7.80 | $2.60 |
Technical Indicators
Market Signals| Indicator | ROC | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 29.40 |
| Support Level | N/A | $1.34 |
| Resistance Level | $4.59 | $1.52 |
| Average True Range (ATR) | 0.28 | 0.12 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 39.58 | 8.53 |
Price Performance
Historical ComparisonAbout ROC Rank One Computing Corporation Common stock
Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.